rs876660540
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_000051.4(ATM):c.4244A>G(p.Tyr1415Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000207 in 1,451,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000051.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATM | NM_000051.4 | c.4244A>G | p.Tyr1415Cys | missense_variant | Exon 29 of 63 | ENST00000675843.1 | NP_000042.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152200Hom.: 0 Cov.: 32 FAILED QC
GnomAD4 exome AF: 0.00000207 AC: 3AN: 1451968Hom.: 0 Cov.: 30 AF XY: 0.00000416 AC XY: 3AN XY: 721534
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74488
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:3
The p.Y1415C variant (also known as c.4244A>G), located in coding exon 28 of the ATM gene, results from an A to G substitution at nucleotide position 4244. The tyrosine at codon 1415 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
PM2_Supporting c.4244A>G, located in exon 29 of the ATM gene, is predicted to result in the substitution of Tyr by Cys at codon 1415, p.(Tyr1415Cys). It is not present in the population database gnomAD v2.1.1, non cancer dataset (PM2_supporting). The SpliceAI algorithm predicts no significant impact on splicing but the REVEL meta-predictor score (0,45) for this variant is indeterminate regarding the effect that it may have on protein function. To our knowledge, neither relevant clinical data (like carriers with ataxia telangiectasia) nor well-stablished functional studies have been reported for this variant. At present ClinVar does not describe pathogenic missense variants in this codon. In addition, this variant has been reported in the ClinVar database (6x uncertain significance) and in the LOVD database (1x uncertain significance). Based on currently available information, the variant c.4244A>G should be considered an uncertain significance variant. -
This missense variant replaces tyrosine with cysteine at codon 1415 of the ATM protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with familial breast cancer (PMID: 30303537). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Ataxia-telangiectasia syndrome Uncertain:2
- -
This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 1415 of the ATM protein (p.Tyr1415Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with breast cancer (PMID: 30303537). ClinVar contains an entry for this variant (Variation ID: 233639). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Identified in an individual with breast cancer (Girard 2019); This variant is associated with the following publications: (PMID: 30303537) -
Familial cancer of breast Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at